85-1382-18　Protein Kinase Inhibitor, aa14-22 Myristoylated (PKI) 1mg　P9103-75

特徴

• Cell permeable cAMP-dependent protein kinase (PKA) inhibitor (protein kinase inhibitor, PKI). The non-myristoylated version of this peptide is a highly specific inhibitor of cAMP-dependent protein kinase (PKA)
• Sequence (linear): Myr-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-NH2
• Amino Acid Analysis:Confirms expected sequencePeptide Content: 80.0 ± 4%
• Solubility: H2O
• Storage and Stability:Lyophilized powder may be stored at 4°C for short-term only. Stable for 12 months at -20°C. Reconstitute (see reconstitution instructions for peptides) and store at -20°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made in assay buffer.

仕様

• Size：1mg
• Grade：Highly Purified
• Purity：~90% by HPLC and MS analysis
• Form：Supplied as a lyophilized powder.
• Molecular Formula：C53H100N20O12
• Molecular Weight Non Ab：1209.51
• EU Commodity Code：38220090
• この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
• 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]